Growth differentiation factor-15 predicts major bleeding, major adverse cardiac events and mortality in patients with end-stage kidney disease on haemodialysis: findings from the VIVALDI study.

MLA

Nopp, Stephan, et al. “Growth Differentiation Factor-15 Predicts Major Bleeding, Major Adverse Cardiac Events and Mortality in Patients with End-Stage Kidney Disease on Haemodialysis: Findings from the VIVALDI Study.” Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association, vol. 38, no. 8, July 2023, pp. 1836–47. EBSCOhost, https://doi.org/10.1093/ndt/gfac321.

APA

Nopp, S., Königsbrügge, O., Schmaldienst, S., Klauser-Braun, R., Lorenz, M., Pabinger, I., Säemann, M., & Ay, C. (2023). Growth differentiation factor-15 predicts major bleeding, major adverse cardiac events and mortality in patients with end-stage kidney disease on haemodialysis: findings from the VIVALDI study. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association, 38(8), 1836–1847. https://doi.org/10.1093/ndt/gfac321

Chicago

Nopp, Stephan, Oliver Königsbrügge, Sabine Schmaldienst, Renate Klauser-Braun, Matthias Lorenz, Ingrid Pabinger, Marcus Säemann, and Cihan Ay. 2023. “Growth Differentiation Factor-15 Predicts Major Bleeding, Major Adverse Cardiac Events and Mortality in Patients with End-Stage Kidney Disease on Haemodialysis: Findings from the VIVALDI Study.” Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association 38 (8): 1836–47. doi:10.1093/ndt/gfac321.